Nov 9 (Reuters) - Activist investor Bill Ackman said Valeant
Pharmaceuticals International Inc's VRX.N VRX.TO stock was
an "extraordinary bargain" given its low price.
More doctors could use specialty pharmacies, potentially
benefiting Valeant, and the selloff in the stock was
unwarranted, Ackman said on Pershing Square's quarterly call on
Monday. urn:newsml:reuters.com:*:nL1N1341HM
He also said he had constructive meeting with the management
of Mondelez International Inc MDLZ.O , in which he took a stake
in August.